541.20
-3.50
(-0.64%)
At close: 5:35:58 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 17 | 14 | 27 | 27 |
| Avg. Estimate | 11.29B | 10.71B | 42.81B | 44.87B |
| Low Estimate | 11.08B | 10.54B | 42.56B | 43.95B |
| High Estimate | 11.51B | 10.88B | 43.22B | 45.62B |
| Year Ago Sales | 10.89B | 10.35B | 42.86B | 42.81B |
| Sales Growth (year/est) | 3.75% | 3.53% | -0.11% | 4.83% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TN8.DE | -- | -- | -- | -- |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight to Overweight | 1/13/2025 |
| Initiated | Scotiabank: Sector Perform | 12/23/2024 |
| Maintains | B of A Securities: Buy to Buy | 12/13/2024 |
| Maintains | Bernstein: Market Perform to Market Perform | 10/24/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 10/24/2024 |
| Maintains | Stifel: Buy to Buy | 10/24/2024 |